Skip to content

Ovarian Inflammatory Response Marker (Serum) – Immunoassay

Published: August 9, 2026Updated: August 16, 2026

This test measures a substance in your blood that may indicate inflammation or immune response activity in the ovaries, often assessed in conditions like endometriosis or pelvic inflammatory disease.

Quick summary

["Helps doctors evaluate ovarian health and inflammation-related issues."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
56962-4
Short code
Ovary IgG Ser Ql IF
Synonyms
Ovary IgG Ser Ql IF
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
if
CPT
82784
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms like chronic pelvic pain, abnormal menstrual cycles, or suspected ovarian inflammation. It can also be part of monitoring for conditions like endometriosis or pelvic inflammatory disease.

What to Expect Before the Test

No special preparation is needed. You’ll have a small needle inserted into your arm for a blood draw, similar to other routine blood tests. The process takes about 5 minutes.

What the Test Results Mean

Results are qualitative (yes/no) and indicate whether inflammation markers were detected in your blood. Elevated levels may suggest ovarian inflammation, but they aren’t diagnostic alone. Your provider will interpret results in the context of your symptoms and medical history.

Common Conditions Monitored

This test is often used to support diagnosis or monitoring of ovarian-related inflammatory conditions, such as endometriosis, pelvic inflammatory disease, or other pelvic pain disorders.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance: Inflammatory Markers in Ovarian Health

Short name

Ovarian Inflammation Marker

Frequently asked questions

Inflammatory markers like this one help identify immune system activity in the ovaries. While not a definitive diagnostic test, they can signal potential issues that may require further evaluation, such as imaging or additional tests, depending on your symptoms and medical history.
This test is not a standalone diagnosis for ovarian cysts, tumors, or other ovarian conditions. It’s often used alongside other tests, like ultrasounds or hormone evaluations, to guide treatment decisions.
What does a positive result mean?
A positive result means your blood contained detectable levels of the marker, suggesting possible ovarian inflammation. This doesn’t confirm a specific diagnosis but may prompt further investigation by your healthcare provider.
How often will I need this test?
Frequency depends on your medical condition and treatment plan. Your doctor will determine how often this test is needed based on your symptoms, response to treatment, or other factors.
  1. 1
    MedlinePlus — Laboratory TestsSource
  2. 2
    Lab Tests OnlineSource
  3. 3
    Mayo Clinic — Tests & ProceduresSource

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy